Novelix Pharmaceuticals Limited (BOM:536565)
69.00
-1.05 (-1.50%)
At close: Nov 16, 2026
| Market Cap | 1.96B +117.2% |
| Revenue (ttm) | 1.55B +82.8% |
| Net Income | 46.58M +390.8% |
| EPS | 1.66 +118.6% |
| Shares Out | 28.47M |
| PE Ratio | 42.24 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,496 |
| Open | 70.05 |
| Previous Close | 70.05 |
| Day's Range | 64.01 - 71.97 |
| 52-Week Range | 49.01 - 92.00 |
| Beta | 0.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 11, 2026 |